The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

Stian Knappskog(Haukeland University Hospital), Per Eystein Lønning(Haukeland University Hospital), Vidar Staalesen(Haukeland University Hospital), Merete Bjørnslett(Oslo University Hospital), Grethe S. Tell(University of Bergen), Lauri A. Aaltonen(Varsinais-Suomen Sairaanhoitopiiri), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Kristian Hveem(Norwegian University of Science and Technology), Christi J. van Asperen(Loyola University Medical Center), Peter Devilee(Leiden University), Lars J. Vatten(Norwegian University of Science and Technology), Maaike P.G. Vreeswijk(Leiden University Medical Center), Petra E.A. Huijts(Leiden University), Hege Edvardsen(Norwegian Cancer Society), Johanna Arola(University of Helsinki), Ming Yang(Beijing University of Chemical Technology), Line M. Myklebust(University of Bergen), Anne Dørum(Oslo University Hospital), Erik Løkkevik(Oslo University Hospital), Camilla Stoltenberg(NORCE Research AS), William G. Newman(Manchester Metropolitan University), Yongli Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Pia Alhopuro(University of Helsinki), D. Gareth Evans(Manchester Academic Health Science Centre), Xuemei Zhang(Hebei Agricultural University), Dongxin Lin(Sun Yat-sen University), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Johan R. Lillehaug(Molecular Biology Consortium), Sanna K. Ylisaukko‐oja(University of Helsinki), Helga B. Salvesen(Haukeland University Hospital), Ranjan Chrisanthar(Haukeland University Hospital), Caroline Seynaeve(Erasmus MC), Pål Romundstad(Norwegian University of Science and Technology)
Cancer Cell
February 1, 2011
Cited by 115


Related Papers